Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial
Grimison, Peter S; Stockler, Martin R; Thomson , Damien B; Olver, Ian N; Harvey, Vernon J; Gebski, Val J; Lewis, Craig R; Levi, John A; Boyer, Michael J; Gurney, Howard; Craft, Paul; Boland, Amy L; Simes, R John; Toner, Guy C
Background The Australian and New Zealand Germ Cell Trials Group conducted a multicenter randomized phase III trial in men with good-prognosis germ cell tumors of two standard chemotherapy regimens that contained bleomycin, etoposide, and cisplatin but differed in the scheduling and total dose of cisplatin, the total dose of bleomycin, and the scheduling and dose intensity of etoposide. The trial was stopped early at a median follow-up of 33 months after a planned interim analysis found a...[Show more]
|Collections||ANU Research Publications|
|Source:||Journal of the National Cancer Institute|
|01_Grimison_Comparison_of_Two_Standard_2010.pdf||387.09 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.